We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
Health . Education . Research . Foundation
A Mater researcher has developed a method to predict breast cancer patient responses to a commonly prescribed breast cancer drug.
Mater researcher Professor Geoff Faulkner and his lab have published a paper that explores the development of resistance to chemotherapy in ovarian cancer. Each year ...
During the month of May Mater commemorates Bladder Cancer Awareness Month to raise awareness for the disease which is the ninth most common cancer worldwide.
A Queensland trial will evaluate the benefits of medicinal cannabis for symptom relief in cancer patients receiving palliative care.
Mater Group Executives are strapping on their walking shoes to take part in this year’s fun run event in support of women with breast cancer who are treated at Mater.
Mater Research is proud to announce that Professor Brian Gabrielli and Professor Jean-Pierre Levesque have been awarded research grants through Cancer Council ...
At Mater, we value effective communication—with staff, patients and the community. To keep up to date with news at Mater, you can review the latest news updates on this page or you can follow us or join the conversation on our social media pages.
A Media and Communications Officer is on-call 24 hours a day, seven days a week. To contact the on-call officer, please call Mater Switch on 07 3163 8111 and ask to be put through to the Media and Communications Officer on-call or give us online feedback